Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/10804
Title: Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
Authors: Lubel, John S;Herath, Chandana B;Tchongue, Jorge;Grace, Josephine A;Jia, Zhiyuan;Spencer, Karen;Casley, David J;Crowley, Peter;Sievert, William;Burrell, Louise M;Angus, Peter W
Affiliation: Department of Medicine, The University of Melbourne, Austin Health and Northern Health, VIC, Australia. johnlubel@me.com
Issue Date: 14-Sep-2009
Citation: Clinical Science (london, England : 1979) 2009; 117(11): 375-86
Abstract: Ang-(1-7) (angiotensin-1-7), a peptide product of the recently described ACE (angiotensin-converting enzyme) homologue ACE2, opposes the harmful actions of AngII (angiotensin II) in cardiovascular tissues, but its role in liver disease is unknown. The aim of the present study was to assess plasma levels of Ang-(1-7) in human liver disease and determine its effects in experimental liver fibrosis. Angiotensin peptide levels were measured in cirrhotic and non-cirrhotic patients with hepatitis C. The effects of Ang-(1-7) on experimental fibrosis were determined using the rat BDL (bile-duct ligation) model. Liver histology, hydroxyproline quantification and expression of fibrosis-related genes were assessed. Expression of RAS (renin-angiotensin system) components and the effects of Ang-(1-7) were examined in rat HSCs (hepatic stellate cells). In human patients with cirrhosis, both plasma Ang-(1-7) and AngII concentrations were markedly elevated (P<0.001). Non-cirrhotic patients with hepatitis C had elevated Ang-(1-7) levels compared with controls (P<0.05), but AngII concentrations were not increased. In BDL rats, Ang-(1-7) improved fibrosis stage and collagen Picrosirius Red staining, and reduced hydroxyproline content, together with decreased gene expression of collagen 1A1, alpha-SMA (smooth muscle actin), VEGF (vascular endothelial growth factor), CTGF (connective tissue growth factor), ACE and mas [the Ang-(1-7) receptor]. Cultured HSCs expressed AT1Rs (AngII type 1 receptors) and mas receptors and, when treated with Ang-(1-7) or the mas receptor agonist AVE 0991, produced less alpha-SMA and hydroxyproline, an effect reversed by the mas receptor antagonist A779. In conclusion, Ang-(1-7) is up-regulated in human liver disease and has antifibrotic actions in a rat model of cirrhosis. The ACE2/Ang-(1-7)/mas receptor axis represents a potential target for antifibrotic therapy in humans.
Internal ID Number: 19371232
URI: http://ahro.austin.org.au/austinjspui/handle/1/10804
DOI: 10.1042/CS20080647
URL: http://www.ncbi.nlm.nih.gov/pubmed/19371232
Type: Journal Article
Subjects: Actins.metabolism
Adult
Angiotensin I.blood.genetics.therapeutic use
Angiotensin II.blood
Animals
Bile Ducts.pathology
Cells, Cultured
Drug Evaluation, Preclinical
Female
Hepatitis C, Chronic.blood.complications
Humans
Hydroxyproline.metabolism
Liver.metabolism
Liver Cirrhosis.blood.virology
Liver Cirrhosis, Experimental.drug therapy.etiology.pathology
Male
Middle Aged
Peptide Fragments.blood.genetics.therapeutic use
Proto-Oncogene Proteins.metabolism
RNA, Messenger.genetics
Rats
Rats, Sprague-Dawley
Receptors, G-Protein-Coupled.metabolism
Renin.blood
Renin-Angiotensin System.physiology
Up-Regulation
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.